Loss of the E3 ubiquitin ligase HACE1 results in enhanced RAC1 signaling contributing to breast cancer progression [66] while eIF2α-mediated downregulation of RAC1 signaling attenuates malignant phenotypes of breast cancer cells [67]. This evidence concerns the gene HACE1 and breast cancer.